Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Effect of different back braces on mobility in older adults with hyperkyphosis

Official title: Effects of Two Thoracic Spinal Orthoses on Gait Biomechanics, Muscle Torque, and Physical Activity in Older Adults With Hyperkyphosis: A Four-Arm Randomized Placebo-Controlled Trial

Run by Pontificia Universidade Católica do Rio Grande do Sul · NCT06970470 · Data updated 2026-11-12

This study tests whether wearing a thoracic back brace helps physically active adults aged 60+ with hyperkyphosis walk more easily.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment100 (estimated)
SponsorPontificia Universidade Católica do Rio Grande do Sul
Academic / other
Locations1 site (Porto Alegre, Rio Grande do Sul)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedDecember 2026
Study endsMarch 2027
Registry record updatedOctober 8, 2026
Trial IDNCT06970470 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Aged 60 years or older with Cobb angle 40 degrees or more, who walk independently and actively participate in the PUCRS PIAFI program.

Probably not a fit

Individuals who cannot tolerate the orthoses, have cognitive impairment affecting participation, or do not adhere to the wear protocol may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, four-arm randomized trial that compares three orthosis strategies and a placebo/no-brace control over 16 weeks in community-dwelling older adults with thoracic hyperkyphosis. Participants are randomly assigned to one of four groups andFollow a progressive wear protocol, with baseline and 16-week assessments of mobility, gait, strength, and biomechanics. Outcomes are collected to see if different braces can improve functional mobility and whether adherence or adverse events affect usability. The study uses gait analysis, isokinetic testing, and accelerometry to quantify changes, with safety monitoring throughout.

Why it matters

Potential benefit: If successful, the braces could improve mobility and reduce fall risk in older adults with hyperkyphosis.

How similar studies have gone: Previous studies in similar populations have shown mixed results; this trial tests multiple brace types and a placebo to clarify effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 60 years or older
* Thoracic hyperkyphosis with Cobb angle of 40 degrees or more (Goniometer-Pro app)
* Ability to walk independently without assistive devices
* Active participation in a supervised physical activity program (Senior Physical Activity Incentive Program - PIAFI, PUCRS)

Exclusion Criteria:

* Cognitive impairment, defined by Mini-Mental State Examination scores below education-adjusted cutoffs
* Inability to complete the required assessments (gait analysis, isokinetic dynamometry, accelerometry)
* Non-compliance with orthosis use during the intervention period
* Discontinuation of participation in the PIAFI supervised exercise program

Where it's running

  • Pontifical Catholic University of Rio Grande do Sul
    Porto Alegre, Rio Grande do Sul, Brazil
    Recruiting

Study contacts

  • Principal investigator: Rafael R Baptista, PhD — Pontifical Catholic University of Rio Grande do Sul
  • Study coordinator: Rafael R Baptista, PhD
  • Email: rafael.baptista@pucrs.br
  • Phone: +5551999996331

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.